INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 99 filers reported holding INFINITY PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $16,000 | -84.0% | 13,691 | -69.2% | 0.00% | -100.0% |
| Q4 2021 | $100,000 | -63.1% | 44,434 | -50.9% | 0.00% | -66.7% |
| Q2 2021 | $271,000 | -63.2% | 90,500 | -60.4% | 0.00% | -66.7% |
| Q1 2021 | $737,000 | +2848.0% | 228,250 | +1615.5% | 0.01% | +800.0% |
| Q1 2019 | $25,000 | -82.3% | 13,305 | -50.3% | 0.00% | -87.5% |
| Q1 2016 | $141,000 | -28.8% | 26,772 | +6.4% | 0.01% | -33.3% |
| Q4 2015 | $198,000 | -25.6% | 25,173 | -20.1% | 0.01% | -7.7% |
| Q3 2015 | $266,000 | +58.3% | 31,501 | +105.5% | 0.01% | +62.5% |
| Q2 2015 | $168,000 | -85.2% | 15,330 | -81.2% | 0.01% | -85.7% |
| Q1 2015 | $1,137,000 | +28.3% | 81,350 | +55.0% | 0.06% | +16.7% |
| Q4 2014 | $886,000 | +2171.8% | 52,476 | +1709.5% | 0.05% | +2300.0% |
| Q3 2014 | $39,000 | – | 2,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 6,353,645 | $4,017,000 | 0.19% |
| Gratus Capital, LLC | 1,117,154 | $706,000 | 0.08% |
| Bleichroeder LP | 250,000 | $158,000 | 0.03% |
| Polar Capital Holdings Plc | 5,000,000 | $3,162,000 | 0.02% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 545,508 | $345,000 | 0.01% |
| Ergoteles LLC | 419,652 | $265,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 249,000 | $157,000 | 0.00% |
| Y-Intercept (Hong Kong) Ltd | 41,396 | $26,000 | 0.00% |
| Heritage Financial Services, LLC | 4,749 | $3,000 | 0.00% |
| Evercore Wealth Management, LLC | 143,138 | $91,000 | 0.00% |